New study tests paliperidone for schizophrenia in 505 bangladeshi adults
Disease control
Not yet recruiting
This study will test the safety and effectiveness of an extended-release medication called paliperidone in 505 adults with schizophrenia in Bangladesh. Participants will take the medication for 12 weeks, and researchers will track changes in symptoms and side effects. The goal is…
Phase: PHASE4 • Sponsor: Sher-E-Bangla Medical College • Aim: Disease control
Last updated May 14, 2026 12:02 UTC